These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 14762605)

  • 21. Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners.
    De Letter M; Santens P; Estercam I; Van Maele G; De Bodt M; Boon P; Van Borsel J
    Clin Linguist Phon; 2007 Oct; 21(10):783-91. PubMed ID: 17882694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential changes in motor speech across a levodopa cycle in advanced Parkinson's disease.
    De Letter M; Van Borsel J; Boon P; De Bodt M; Dhooge I; Santens P
    Int J Speech Lang Pathol; 2010 Oct; 12(5):405-13. PubMed ID: 20602581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glottographic measures before and after levodopa treatment in Parkinson's disease.
    Jiang J; Lin E; Wang J; Hanson DG
    Laryngoscope; 1999 Aug; 109(8):1287-94. PubMed ID: 10443835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Articulation disorders and duration, severity and L-dopa dosage in idiopathic Parkinson's disease.
    Pawlukowska W; Gołąb-Janowska M; Safranow K; Rotter I; Amernik K; Honczarenko K; Nowacki P
    Neurol Neurochir Pol; 2015; 49(5):302-6. PubMed ID: 26377981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
    Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B
    Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of levodopa on vocal function in Parkinson's disease.
    Sanabria J; Ruiz PG; Gutierrez R; Marquez F; Escobar P; Gentil M; Cenjor C
    Clin Neuropharmacol; 2001; 24(2):99-102. PubMed ID: 11307045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of speech impairment in early stages of Parkinson's disease: a prospective study with the role of pharmacotherapy.
    Rusz J; Cmejla R; Růžičková H; Klempíř J; Majerová V; Picmausová J; Roth J; Růžička E
    J Neural Transm (Vienna); 2013 Feb; 120(2):319-29. PubMed ID: 22772465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Parkinson's disease and levodopa on resting state functional connectivity related to speech prosody control.
    Elfmarková N; Gajdoš M; Mračková M; Mekyska J; Mikl M; Rektorová I
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S52-5. PubMed ID: 26363673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of levodopa treatment in the voice pattern of Parkinson's disease patients: a systematic review and meta-analysis.
    Pinho P; Monteiro L; Soares MFP; Tourinho L; Melo A; Nóbrega AC
    Codas; 2018 Oct; 30(5):e20170200. PubMed ID: 30304100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease.
    Goberman AM
    Med Sci Monit; 2005 Mar; 11(3):CR109-16. PubMed ID: 15735562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acoustic analysis of parkinsonian speech II: L-Dopa related fluctuations and methodological issues.
    Goberman AM; Coelho C
    NeuroRehabilitation; 2002; 17(3):247-54. PubMed ID: 12237506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.
    Warren Olanow C; Kieburtz K; Rascol O; Poewe W; Schapira AH; Emre M; Nissinen H; Leinonen M; Stocchi F;
    Mov Disord; 2013 Jul; 28(8):1064-71. PubMed ID: 23630119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imprecise vowel articulation as a potential early marker of Parkinson's disease: effect of speaking task.
    Rusz J; Cmejla R; Tykalova T; Ruzickova H; Klempir J; Majerova V; Picmausova J; Roth J; Ruzicka E
    J Acoust Soc Am; 2013 Sep; 134(3):2171-81. PubMed ID: 23967947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Speech dysfluency exacerbated by levodopa in Parkinson's disease.
    Louis ED; Winfield L; Fahn S; Ford B
    Mov Disord; 2001 May; 16(3):562-5. PubMed ID: 11391759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involuntary expiratory phonation as a dose-related consequence of L-dopa therapy in a patient with Parkinson's disease.
    Ishii K; Kumada M; Ueki A; Yamamoto M; Hirose H
    Ann Otol Rhinol Laryngol; 2003 Dec; 112(12):1040-2. PubMed ID: 14703107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basic parameters of articulatory movements and acoustics in individuals with Parkinson's disease.
    Walsh B; Smith A
    Mov Disord; 2012 Jun; 27(7):843-50. PubMed ID: 22729986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Aerodynamic Study of Phonations in Patients With Parkinson Disease (PD).
    Ikui Y; Nakamura H; Sano D; Hyakusoku H; Kishida H; Kudo Y; Joki H; Koyano S; Yamauchi A; Takano S; Tayama N; Hirose H; Oridate N; Tanaka F
    J Voice; 2015 May; 29(3):273-80. PubMed ID: 25795370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of selegiline on speech performance in Parkinson's disease.
    Shea BR; Drummond SS; Metzer WS; Krueger KM
    Folia Phoniatr (Basel); 1993; 45(1):40-6. PubMed ID: 8482574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic polymorphism of the angiotensin converting enzyme and L-dopa-induced adverse effects in Parkinson's disease.
    Lin JJ; Yueh KC; Lin SZ; Harn HJ; Liu JT
    J Neurol Sci; 2007 Jan; 252(2):130-4. PubMed ID: 17196621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.